Professor Fisk has a sustained record of clinical innovation as an obstetrician/fetal medicine specialist. He has pioneered significant advances in understanding fetoplacental disease and its treatment including characterising early human fetal stem cell populations, documenting “fetal pain” and its blockade by opioid analgesia, and unravelling the vascular basis of twin-to-twin transfusion syndrome. Professor Fisk has a longstanding record of leadership advancing the health and medical profession, and is strongly committed to community outreach and engagement. In a professorial career spanning more than 20 years, Professor Fisk has lectured widely in clinical education fora and advocated strongly for national/state guideline development.